Jason Pontin
VCGeneral Partner, DCVC (Data Collective)
Computational biology and drug discovery investor
Palo Alto, CA2 notable investments
Pre-SeedSeedSeries A
BioHealthcareAIDeep TechData
Background
Jason Pontin joined DCVC in 2021 after three years at Flagship Pioneering. He cofounded Totus Medicines in 2020, a chemical biology platform for drug discovery. He was previously editor-in-chief of MIT Technology Review for 13 years. He studied at Oxford University and divides his time between Palo Alto and London. He focuses on computational biology and chemistry startups treating intractable diseases.
Investment Thesis
Back early-stage computational biology and chemistry startups treating previously intractable diseases and transforming dirty industries.
Investment Focus
Stages
Pre-SeedSeedSeries A
Sectors
BioHealthcareAIDeep TechData
Based in: Palo Alto, CA (North America)
Notable Investments
Last updated: Jun 11, 2026